Cargando…
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia
BACKGROUND: Berberine, an alkaloid with both glucose- and cholesterol-lowering action, is also characterized by an anti-diarrheal effect. Consequently, berberine-based therapies are recommended for diabetic patients with irritable bowel syndrome (IBS) or gut discomfort caused by metformin. AIM: As t...
Autores principales: | Di Pierro, Francesco, Putignano, Pietro, Villanova, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166165/ https://www.ncbi.nlm.nih.gov/pubmed/29350661 http://dx.doi.org/10.23750/abm.v88i4.5851 |
Ejemplares similares
-
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia
por: Di Pierro, Francesco, et al.
Publicado: (2016) -
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
por: Di Pierro, Francesco, et al.
Publicado: (2013) -
Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
por: Di Pierro, Francesco, et al.
Publicado: (2015) -
Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial
por: Giuseppe, Derosa, et al.
Publicado: (2017) -
Detailed pharmacognostical studies on Berberis aristata DC plant
por: Rathi, Bhawana, et al.
Publicado: (2013)